SFEBES2009 Poster Presentations Cytokines and growth factors (8 abstracts)
Institute for Biomedical Research into Human Movement and Health, Manchester, UK.
Inflamed ageing is associated with reduced muscle mass and increased susceptibility to TNF-induced muscle protein degradation. We therefore aimed to elucidate mechanisms supporting reduced hypertrophy and increased atrophy of skeletal myoblasts. C2 myoblasts display diminished differentiation and increased susceptibility to TNF-α-induced apoptosis versus daughter C2C12 cells, providing us with relevant models. C2 and C2C12 cells were cultured for 72 h±TNF-α (20 ng/ml), to assess differentiation (creatine kinase), proliferation (protein), death (trypan blue) and anabolic/catabolic parameters (RT-PCR). Under basal conditions, larger myotubes were evident in C2C12 versus C2 cells. Significantly higher CK activity (320.3±6.8 vs 30.7±2.5, P<0.05; 544.9±27.7 vs 39.4±3.4 μmg/ml, P<0.05), and fold increases in myoD (21.5±3.1 vs 4±1.8, P<0.05; 31.1±3.1 vs 6.8±1.9, P<0.05) and myogenin mRNA (241.8±40 vs 36.80±19.3, P<0.05; 440±100.5 vs 201.1±86, P<0.05) were detected at 48 and 72 h, respectively. Fold increases in IGF1 mRNA (243.1±3.1 vs 105.7±21.9, P<0.05), together with reduced proliferation and significantly lower protein expression (1.21±0.28 vs 1.79±0.29 mg/ml, P<0.05) were evident at 72 h. Significant fold reductions in IGFBP2 mRNA occurred in the C2C12 cells (15.04±2.91, 8.27±4.27, 4.21±2.09, P<0.05) versus increases in the C2 cells (1.61±0.803, 11.98±2.26, 18.38±3.56, P<0.05) at 0, 48 and 72 h, respectively. TNF-α increased apoptosis in the C2 cells (2.67±1.54, 34.42±5.39, 29.71±5.79% (0, 48, 72 h), P<0.05)), was without effect in the C2C12s at 48 h but caused a small significant increase at 72 h (9.88±4.02% (TNF-α) versus 6.17±0.749% (DM), 72 h)). TNF-α and TNFRI mRNA were unchanged, however, larger reductions in IGF1 (8.2 and 7.5 vs 4.5 and 4.1-fold (48, 72 h)) and IGFBP5 (2.7 versus no reduction (48 h) P<0.05)) mRNA were observed in C2 versus C2C12 cells in the presence of TNF-α. This model provides insight into altered hypertrophic/atrophic and myogenic regulators of basal and TNF-induced adaptations of skeletal muscle and may provide insight into therapeutic initiatives for ageing and wasting disorders.